BAT Bangladesh, the leading player in the cigarette industry in Bangladesh, reported a decrease in income for the period of April-June 2023. The company recorded a total income of Tk 493 crore, compared to Tk 496 crore in the same period last year.
However, when considering their earnings for the first half of the year, including the second quarter, BAT Bangladesh's overall earnings stood at Tk 949 crore. This was an increase from Tk 913 crore in the same period last year.
The earnings per share (EPS) of the tobacco products manufacturer also increased by 4 percent to Tk 17.59 in January-June. The company attributed this growth to an increase in volume and higher leaf export.
Despite the financial performance, shares of BAT Bangladesh remained constant at Tk 518.7 on the Dhaka Stock Exchange.
Regarding sales, BAT Bangladesh reported a total sales of Tk 21,229 crore for the first half of 2023, experiencing a 14 percent year-on-year growth. This information was revealed through the company's unaudited financial statement released recently.
In the April-June period, the multinational company recorded a 15 percent increase in sales, reaching Tk 11,329 crore.
Overall, BAT Bangladesh has seen mixed results in their recent financial report. While they experienced a decline in income for April-June, their overall earnings for the first half of the year showed improvement. The rise in sales can be attributed to the company's volume growth and higher leaf export. However, the market response seemed to be relatively stable, with shares remaining unchanged on the Dhaka Stock Exchange.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
